Vaccine Adjuvants Market Poised for Remarkable Growth: Projections Suggest a Worth $1.2 Billion, Reveals MnM Analysis
Vaccine Adjuvants Market in terms of revenue was estimated to be worth $0.8 billion in 2023 and is poised to reach $1.2 billion by 2028, growing at a CAGR of 6.9 % from 2023 to 2028 according to a new report by MarketsandMarkets™. The global vaccine adjuvants market is expected to grow at a CAGR of 6.9% during the forecast period. The major factors driving the...
0 Комментарии 0 Поделились 1084 Просмотры 0 предпросмотр
Спонсоры